About
Extracts for allergy and immunology
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (23)
View allTotal Trials
23
As Lead Sponsor
22
As Collaborator
1
Total Enrollment
2,642
By Phase
NA: 5PHASE2/PHASE3: 2PHASE1/PHASE2: 1PHASE3: 9PHASE2: 3
By Status
COMPLETED: 8RECRUITING: 7UNKNOWN: 3NOT_YET_RECRUITING: 2TERMINATED: 1WITHDRAWN: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline22 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07195929Lead Sponsor
Determination of Blomia Tropicalis Allergen Extract in Prick Test Units
NANot yet recruiting
30 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2027
NCT06790368Lead Sponsor
Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.
N/ARecruiting
80 participants
Started: Jan 1, 2025 · Completed: Jun 1, 2026
NCT06957496Lead Sponsor
Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization
NACompleted
31 participants
Started: Dec 9, 2024 · Completed: Jan 16, 2025
NCT06782217Lead Sponsor
Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
N/ARecruiting
120 participants
Started: Sep 1, 2024 · Completed: Feb 1, 2027
NCT05641272Lead Sponsor
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
PHASE2/PHASE3Not yet recruiting
90 participants
Started: Nov 1, 2023 · Completed: Dec 1, 2026
Locations (1)
Headquarters
Madrid, Spain
Map
Loading map...